Hemoglobin News and Research

RSS

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.

27 Sep 2010

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes inadequately controlled on metformin therapy alone.

24 Sep 2010

Boehringer Ingelheim to present linagliptin Phase III data at 46th EASD

New Phase III data found that investigational linagliptin therapy resulted in significant reductions in blood sugar as measured by hemoglobin A1c (HbA1c) when compared to placebo, both when added to sulfonylurea (SU) in inadequately controlled type 2 diabetes (T2D) patients, and when administered as monotherapy in T2D patients for whom metformin is inappropriate.

22 Sep 2010

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

22 Sep 2010

FG-4592 oral anemia therapy receives CTA approval from SFDA

FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.

21 Sep 2010

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2 diabetes compared to glimepiride alone.

20 Sep 2010

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio an emerging leader in the development of innovative gene therapies for severe genetic disorders, today announced publication in the journal Nature of its promising Phase 1/2 data highlighting positive results of LentiGlobin gene therapy treatment in a young adult with severe beta-thalassemia, a blood disorder that is one of the most frequent inherited diseases.

16 Sep 2010

Dartmouth study says primary care not always a cure-all

A new study by Dartmouth Health Atlas researchers contends that making primary care more widely accessible -- one of the goals of the health overhaul -- won't necessarily improve the nation's health, Reuters reports. The researchers found wide variations in the quality of care that do not always match up with the level of access to physicians.

10 Sep 2010

Researchers find risk prediction model for VTE in cancer patients

For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology.

10 Sep 2010

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

Giving iron supplements to children with marginally low birth weights (2000-2500 grams) dramatically reduces the risk of developing iron deficiency and anemia. This is shown by Umeå researcher Magnus Domellöf and associates in the coming edition of the pediatric scientific journal Pediatrics.

6 Sep 2010

NYBC calls for blood donations as Hurricane Earl approaches

New York Blood Center, serving more than 20 million people in New York City, Long Island, the Hudson Valley and New Jersey, calls upon our communities to please donate blood and platelets, as the East Coast braces for Hurricane Earl. While donations from Rh-negative types are especially crucial, healthy people of all blood types and ethnicities are encouraged to donate.

3 Sep 2010

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Fluoride avoidance reduced anemia in pregnant women, decreased pre-term births and enhanced babies' birth-weight, concludes leading fluoride expert, AK Susheela and colleagues, in a study published in Current Science (May 2010).

3 Sep 2010

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients.

2 Sep 2010

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

31 Aug 2010

National Association of Free Clinic available to uninsured residents in New Orleans

Free HIV/AIDS tests, other significant tests and medical exams (including physicals) will be available to uninsured residents of the area when the National Association of Free Clinics holds a massive free clinic in New Orleans on Aug. 31 and Sept 1.

27 Aug 2010

Study finds sexual problem common among diabetic patients

Many middle-aged and older adults with diabetes are sexually active according to a study of nearly 2,000 people aged 57 to 85 presented in the September 2010 issue of the journal Diabetes Care. Almost 70 percent of partnered men with diabetes and 62 percent of partnered women with diabetes engaged in sexual activity two or three times a month, comparable to those without diabetes, the study showed.

27 Aug 2010

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.

27 Aug 2010

NYBC calls for blood donation in remembrance of 9/11 victims

New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to please donate blood in honor and remembrance of the thousands of men, women, and children affected by the terrorist attacks of September 11, 2001. Each pint of blood donated can potentially save the lives of three people through the use of blood and blood products.

26 Aug 2010

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.

23 Aug 2010

Assessment of critical illness during Emergency Medical Services care

A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.

19 Aug 2010

Hemoglobin News and Research

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Boehringer Ingelheim to present linagliptin Phase III data at 46th EASD

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

FG-4592 oral anemia therapy receives CTA approval from SFDA

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

Dartmouth study says primary care not always a cure-all

Researchers find risk prediction model for VTE in cancer patients

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

NYBC calls for blood donations as Hurricane Earl approaches

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

National Association of Free Clinic available to uninsured residents in New Orleans

Study finds sexual problem common among diabetic patients

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

NYBC calls for blood donation in remembrance of 9/11 victims

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Assessment of critical illness during Emergency Medical Services care

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News